BioSpace News Archive

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2022 second-quarter conference call on Thursday, February 3, 2022, at 8:00 a.m. CT (9:00 a.m. ET).

The global bioengineered protein drugs market is highly competitive due to presence of numerous and strong players, observes Transparency Market Research.

According to the report, the global assistive technologies for visually impaired market was valued at US$ 3.5 Bn in 2020 and is projected to expand at a CAGR of 13.7% from 2021 to 2031.

Pixium Vision SA announces that Lloyd Diamond, Chief Executive Officer of Pixium Vision, will attend the BIOMED EVENT® by Invest Securities, being held on Wednesday, January 26, 2022.

Valneva SE, a specialty vaccine company, confirms the previously communicated timelines of its clinical trials and regulatory submissions for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.

Photocure ASA announces that President and Chief Executive Officer, Dan Schneider and Chief Financial Officer, Erik Dahl are scheduled to present a corporate overview and participate in meetings with investors at the H.C. Wainwright BioConnect 2022 Virtual Conference to be held January 10-13, 2022.

Fact.MR – A Market Research and Competitive Intelligence Provider: The rising prevalence of dental ailments such as periodontal disease, dental caries, and tooth decay is driving up demand for prophylaxis pastes.

The global aptamer market was valued at approximately US$ 1.0 Bn in 2016 is projected to register cumulative annual growth rate of over 20.0% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Aptamer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that CEO, Tim Dyer, will present at the H.C. Wainwright BIOCONNECT Virtual Conference.

ONWARD Medical N.V. announces the company and its partners have been awarded nine new patents, seven of them in collaboration with leading neuroscience research laboratories at Caltech, UCLA, EPFL, and University of Louisville.